ARTL (Artelo Biosciences, Inc. Common Stock) Stock Analysis - SEC Filings

Artelo Biosciences, Inc. Common Stock (ARTL) is a publicly traded Healthcare sector company. As of May 21, 2026, ARTL trades at $1.43 with a market cap of $3.19M and a P/E ratio of 0.00. ARTL moved +3.68% today. Year to date, ARTL is -63.59%; over the trailing twelve months it is -91.84%. Its 52-week range spans $1.25 to $85.80. Rallies surfaces ARTL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find ARTL SEC filings?

Rallies organizes ARTL SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

ARTL Key Metrics

Key financial metrics for ARTL
MetricValue
Price$1.43
Market Cap$3.19M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$85.80
52-Week Low$1.25
Volume9.98K
Avg Volume0
Revenue (TTM)$0
Net Income$-9.83M
Gross Margin0.00%

Latest ARTL News

Recent ARTL Insider Trades

  • Gorgas Gregory D. bought 1.20K (~$4.80K) on Aug 12, 2022.
  • Gorgas Gregory D. bought 1.20K (~$4.84K) on Aug 11, 2022.

ARTL Analyst Consensus

ARTL analyst coverage data. Average price target: $0.00.

Common questions about ARTL

Where can I find ARTL SEC filings?
Rallies organizes ARTL SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show ARTL 10-K and 10-Q filings?
Rallies organizes ARTL SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is ARTL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ARTL. It does not provide personalized investment advice.
ARTL

ARTL